These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Acute effects of GM1 ganglioside: reduction in both behavioral asymmetry and loss of Na+, K+-ATPase after nigrostriatal transection. Li YS; Mahadik SP; Rapport MM; Karpiak SE Brain Res; 1986 Jul; 377(2):292-7. PubMed ID: 3015350 [TBL] [Abstract][Full Text] [Related]
6. [Effect of dipfluzine on acute ischemic brain edema in gerbils]. Bai J; Wang Y Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1130-2. PubMed ID: 12425827 [TBL] [Abstract][Full Text] [Related]
7. Classification of ischemic-induced damage to Na+, K+-ATPase in gerbil forebrain. Modification by therapeutic agents. Palmer GC; Palmer SJ; Christie-Pope BC; Callahan AS; Taylor MD; Eddy LJ Neuropharmacology; 1985 Jun; 24(6):509-16. PubMed ID: 2991803 [TBL] [Abstract][Full Text] [Related]
8. Gangliosides reduce mortality due to global ischemia: membrane protection. Karpiak SE; Li YS; Mahadik SP Clin Neuropharmacol; 1986; 9 Suppl 4():338-40. PubMed ID: 3032429 [No Abstract] [Full Text] [Related]
9. Activation of (Na+, K+)-ATPase by nanomolar concentrations of GM1 ganglioside. Leon A; Facci L; Toffano G; Sonnino S; Tettamanti G J Neurochem; 1981 Aug; 37(2):350-7. PubMed ID: 6267200 [TBL] [Abstract][Full Text] [Related]
13. Chronic daily administration of ethyl docosahexaenoate protects against gerbil brain ischemic damage through reduction of arachidonic acid liberation and accumulation. Cao D; Yang B; Hou L; Xu J; Xue R; Sun L; Zhou C; Liu Z J Nutr Biochem; 2007 May; 18(5):297-304. PubMed ID: 16860980 [TBL] [Abstract][Full Text] [Related]
14. Effect of the ganglioside GM1 on neurologic function, electroencephalogram amplitude, and histology in chronic middle cerebral artery occlusion in cats. Komatsumoto S; Greenberg JH; Hickey WF; Reivich M Stroke; 1988 Aug; 19(8):1027-35. PubMed ID: 3400101 [TBL] [Abstract][Full Text] [Related]
15. Effects of MK-801 and ganglioside GM1 on postischemic prostanoid release and hippocampal lesion in gerbil brain. Lazarewicz JW; Salińska E; Speina E; Gadamski R Acta Neurobiol Exp (Wars); 1994; 54(4):293-305. PubMed ID: 7887181 [TBL] [Abstract][Full Text] [Related]
16. Monosialoganglioside GM1 in cerebral ischemia. Carolei A; Fieschi C; Bruno R; Toffano G Cerebrovasc Brain Metab Rev; 1991; 3(2):134-57. PubMed ID: 1854596 [TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review. Zhang W; Krafft PR; Wang T; Zhang JH; Li L; Tang J Cell Transplant; 2019 Jun; 28(6):657-661. PubMed ID: 30666888 [TBL] [Abstract][Full Text] [Related]
18. Failure of GM1 ganglioside to influence outcome in experimental focal ischemia. Mayer SA; Pulsinelli WA Stroke; 1992 Feb; 23(2):242-6. PubMed ID: 1561655 [TBL] [Abstract][Full Text] [Related]
19. [Effects of oxidative stress inducers, neurotoxins, and ganglioside GM1 on Na+, K+-ATPase in PC12 and brain synaptosomes]. Zakharova IO; Sokolova TV; Furaev VV; Rychkova MP; Avrova NF Zh Evol Biokhim Fiziol; 2007; 43(2):148-54. PubMed ID: 17674707 [TBL] [Abstract][Full Text] [Related]
20. Monosialoganglioside GM1 treatment after a hypoxic-ischemic episode reduces the vulnerability of the fetal sheep brain to subsequent injuries. Tan WK; Williams CE; Mallard CE; Gluckman PD Am J Obstet Gynecol; 1994 Feb; 170(2):663-9. PubMed ID: 8116729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]